Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Moros

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Mount Sinai Journal of Medicine, New York|January 1, 1993
Consumerism rampant: a critique of the view of medicine as a commercial enterpriseD A Moros
The Mount Sinai Journal of Medicine, New York|March 1, 1996
Violence and the physician's duty: a panel discussionD A Moros
Perspectives in Biology and Medicine|January 1, 1987
The philosophy of medicine: clinical science and its ethicsD A Moros
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|July 15, 1998
Putting universal healthcare on the religious agendaD A Moros, R Rhodes
Hospital & Community Psychiatry|April 1, 1984
Movement disorders in the psychiatric patientD A Moros, M D Yahr
Archives of Neurology|January 1, 1991
Early combination of selegiline and low-dose levodopa as initial symptomatic therapy in Parkinson's disease. Experience in 26 patients receiving combined therapy for 26 monthsT S Elizan, D A Moros, M D Yahr
The Journal of Medicine and Philosophy|April 1, 1991
Chronic illness and the physician-patient relationship: a response to the Hastings Center's "ethical challenges of chronic illness"D A Moros, R Rhodes, B Baumrin, et al.
The Mount Sinai Journal of Medicine, New York|May 1, 1989
Issues in medical ethics. IntroductionD A Moros, R Rhodes, B Baumrin, et al.
The American Journal of Medicine|July 1, 1990
Respiratory dysfunction due to L-dopa therapy for parkinsonism: diagnosis using serial pulmonary function tests and respiratory inductive plethysmographyH M Zupnick, L K Brown, A Miller, et al.
Advances in Neurology|January 1, 1990
L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patientsT S Elizan, M D Yahr, D A Moros, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Mount Sinai Journal of Medicine, New York|January 1, 1993
Consumerism rampant: a critique of the view of medicine as a commercial enterpriseD A Moros
The Mount Sinai Journal of Medicine, New York|March 1, 1996
Violence and the physician's duty: a panel discussionD A Moros
Perspectives in Biology and Medicine|January 1, 1987
The philosophy of medicine: clinical science and its ethicsD A Moros
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|July 15, 1998
Putting universal healthcare on the religious agendaD A Moros, R Rhodes
Hospital & Community Psychiatry|April 1, 1984
Movement disorders in the psychiatric patientD A Moros, M D Yahr
Archives of Neurology|January 1, 1991
Early combination of selegiline and low-dose levodopa as initial symptomatic therapy in Parkinson's disease. Experience in 26 patients receiving combined therapy for 26 monthsT S Elizan, D A Moros, M D Yahr
The Journal of Medicine and Philosophy|April 1, 1991
Chronic illness and the physician-patient relationship: a response to the Hastings Center's "ethical challenges of chronic illness"D A Moros, R Rhodes, B Baumrin, et al.
The Mount Sinai Journal of Medicine, New York|May 1, 1989
Issues in medical ethics. IntroductionD A Moros, R Rhodes, B Baumrin, et al.
The American Journal of Medicine|July 1, 1990
Respiratory dysfunction due to L-dopa therapy for parkinsonism: diagnosis using serial pulmonary function tests and respiratory inductive plethysmographyH M Zupnick, L K Brown, A Miller, et al.
Advances in Neurology|January 1, 1990
L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patientsT S Elizan, M D Yahr, D A Moros, et al.
Pageof 2